—
Preparation of the European Council meeting of 16-17 December 2021 - The EU's response to the global resurgence of Covid-19 and the new emerging Covid variants (debate)
The latest COVID variant omikron boosted the stock prices of Pfizer and Moderna considerably. Pfizer saw its share close 6.1 percent higher, about $17.5 billion in additional market value. Competitor Moderna even saw its shares increase by 21 percent. A virus variant such as . This is particularly cynical. After all, it is precisely Big Pharma's patents that make new variants more likely. Patents shield vaccine technology from other countries and companies. This limits vaccine production and increases global shortages at the expense of global health. In poor countries, only 3% of the population is fully vaccinated. These vaccine shortages facilitate virus circulation and hotbeds for new virus variants. The Omicron variant shows how urgently this needs to change. A open source-approach could allow researchers around the world to work on adapting the vaccine to new variants. This would allow the activation of unused production capacity and the creation of new production units within a few months. The removal of patents has never been more urgent. This Parliament has already voted in favour of it three times. What are you waiting for? Are Big Pharma's profits really that much more important to you than human lives? Basta lockdowns. Basta pandemic. Share the technology. Save lives.